Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History SCYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics SCYX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Scynexis Inc

SCYX
Current price
0.73 USD -0.015 USD (-2.03%)
Last closed 0.74 USD
ISIN US8112922005
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 28 875 022 USD
Yield for 12 month -65.88 %
1Y
3Y
5Y
10Y
15Y
SCYX
21.11.2021 - 28.11.2021

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey. Address: 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.67 USD

P/E Ratio

Dividend Yield

Financials SCYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures SCYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+3 746 000 USD

Last Year

+140 141 000 USD

Current Quarter

+257 000 USD

Last Quarter

+977 000 USD

Current Year

+3 746 000 USD

Last Year

+124 517 000 USD

Current Quarter

+257 000 USD

Last Quarter

+977 000 USD
EBITDA -36 537 000 USD
Operating Margin TTM -3 350.20 %
Price to Earnings
Return On Assets TTM -24.32 %
PEG Ratio
Return On Equity TTM -43.47 %
Wall Street Target Price 4.67 USD
Revenue TTM 2 630 000 USD
Book Value 1.30 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -81.30 %
Dividend Yield
Gross Profit TTM 2 630 000 USD
Earnings per share -0.56 USD
Diluted Eps TTM -0.56 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation SCYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.09
Enterprise Value Revenue 0.44
Price Sales TTM 10.98
Enterprise Value EBITDA 0.055
Price Book MRQ 0.59

Technical Indicators SCYX

For 52 Weeks

0.66 USD 2.28 USD
50 Day MA 0.83 USD
Shares Short Prior Month 623 221
200 Day MA 1.08 USD
Short Ratio 3.17
Shares Short 606 406
Short Percent 2.03 %